ICCC
Immucell·NASDAQ
--
--(--)
--
--(--)
ICCC fundamentals
Immucell (ICCC) expects to report earnings on May 12, 2022, with estimated revenue of -- (YoY 0.00%), and EPS at -- (YoY 0.00%).
Revenue estimate / YoY
--
0.00%
EPS estimate / YoY
--
0.00%
Report date
May 12, 2022
EPS
Revenue
Revenue & Expenses
ICCC has released its 2025 Q3 earnings report, with revenue of 5.51M, reflecting a YoY change of -8.41%, and net profit of -139.75K, showing a YoY change of 80.08%. The Sankey diagram below clearly presents ICCC's revenue sources and cost distribution.
Key Indicators
Immucell (ICCC) key financial stats and ratios, covering profitability, financial health, and leverage.
Immucell (ICCC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Immucell (ICCC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Immucell (ICCC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Immucell (ICCC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Immucell (ICCC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Immucell's revenue and profit?What does Immucell do and what are its main business segments?What were the key takeaways from Immucell’s earnings call?What were the key takeaways from Immucell's earnings call?What is Immucell's gross profit margin?What is the market's earnings forecast for Immucell next quarter?What guidance did Immucell's management provide for the next earnings period?Did Immucell beat or miss consensus estimates last quarter?
